{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:50:57Z","timestamp":1782219057991,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neuroscience.2026.01.035","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:24:49Z","timestamp":1769790289000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Isobolographic analysis of clonidine and clozapine\u2019s antidepressant- and anxiogenic-like effects"],"prefix":"10.1016","volume":"598","author":[{"given":"Ali","family":"Arjangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5147-9208","authenticated-orcid":false,"given":"Mohaddeseh","family":"Ebrahimi-Ghiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khakpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakineh","family":"Alijanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.01.035_b0005","doi-asserted-by":"crossref","unstructured":"Allegra S, Chiara F, Di Grazia D, Gaspari M, De Francia S (2023) Evaluation of sex differences in preclinical pharmacology research: how far is left to go? Pharmaceuticals (Basel) 16.","DOI":"10.3390\/ph16060786"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2008.03.023","article-title":"Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments","volume":"1211","author":"Balu","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.neuropharm.2016.02.010","article-title":"Modulatory effects of the basolateral amygdala alpha2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze","volume":"105","author":"Bashiri","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0020","article-title":"The gut-brain-circadian axis in anxiety and depression: a critical review","volume":"16","author":"Bautista","year":"2025","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02246153","article-title":"Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons","volume":"119","author":"Benvenga","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0030","doi-asserted-by":"crossref","unstructured":"Bierwirth P, Stockhorst U (2022) Neurobiology of Learning and Memory Role of noradrenergic arousal for fear extinction processes in rodents and humans. Neurobiol Learn Mem 194:107660 Available at: https:\/\/doi.org\/10.1016\/j.nlm.2022.107660.","DOI":"10.1016\/j.nlm.2022.107660"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.08.007","article-title":"Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function","volume":"56","author":"Cameron","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.037","article-title":"\u03b12A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons","volume":"332","author":"Castelli","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(91)90144-F","article-title":"Clonidine causes antidepressant-like effects in rats by activating alpha 2-adrenoceptors outside the locus coeruleus","volume":"193","author":"Cervo","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2025.138416","article-title":"Ferulic acid possesses anxiolytic activity: evidence for the involvement of serotonergic and noradrenergic systems","volume":"869","author":"Cetiner","year":"2025","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0055","doi-asserted-by":"crossref","unstructured":"Charney DS (2003) Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand Suppl:38\u201350.","DOI":"10.1034\/j.1600-0447.108.s417.3.x"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149304","article-title":"Synergistic interaction between clonidine and ACPA on the modulation of anxiety-like behaviors in non-acute restraint stress and acute restraint stress conditions","volume":"1847","author":"Chitsaz","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0065","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.neubiorev.2012.07.011","article-title":"\u03b12 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy","volume":"36","author":"Cottingham","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(93)90530-U","article-title":"Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs","volume":"249","author":"De Vry","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1471-4159.2003.02239.x","article-title":"Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex","volume":"88","author":"Devoto","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.115142","article-title":"Caffeine attenuates anxiety- and depressive-like behavior following cyclosporine administration in mice, possibly via an NO pathway","volume":"303","author":"Ebrahimi-Ghiri","year":"2026","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-384921-2.00007-0","article-title":"Pre- versus postsynaptic signaling by \u03b1(2)-adrenoceptors","volume":"67","author":"Gilsbach","year":"2011","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0090","volume":"97\u2013101","author":"G\u00fcm\u00fc\u015fl\u00fc","year":"2019","journal-title":"Effects of olanzapine and clozapine on depression and anxiety in mice : alterations in brain neurotrophic factor expression levels."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0091-3057(96)00064-0","article-title":"Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear","volume":"55","author":"Inoue","year":"1996","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.0953-8194.2004.01172.x","article-title":"Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus","volume":"16","author":"Itoi","year":"2004","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01308-6","article-title":"alpha2C-adrenoceptor blockade by clozapine and other antipsychotic drugs","volume":"462","author":"Kalkman","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0110","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/sj.bjp.0701975","article-title":"The role of \u03b12-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat","volume":"124","author":"Kalkman","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2006.04.004","article-title":"Behavioural effects of chronic haloperidol and risperidone treatment in rats","volume":"171","author":"Karl","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150879","article-title":"Anxiolytic- and antidepressive-like effects of harmaline in mice are mediated via histamine H3 receptor blockade","volume":"736","author":"Khakpai","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuint.2007.06.036","article-title":"Alpha2-adrenoceptor subtypes\u2013unexpected functions for receptors and ligands derived from gene-targeted mouse models","volume":"51","author":"Knaus","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0130","doi-asserted-by":"crossref","unstructured":"Kotagale NR, Ali MT, Chopde CT, Umekar MJ, Taksande BG (2018) Agmatine inhibits nicotine withdrawal induced cognitive deficits in inhibitory avoidance task in rats: Contribution of \u03b12-adrenoceptors. Pharmacol Biochem Behav 167:42\u201349 Available at: https:\/\/doi.org\/10.1016\/j.pbb.2018.03.002.","DOI":"10.1016\/j.pbb.2018.03.002"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4522(02)00185-9","article-title":"Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice","volume":"113","author":"L\u00e4hdesm\u00e4ki","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bdi.12272","article-title":"Clozapine for treatment-resistant bipolar disorder: a systematic review","volume":"17","author":"Li","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyg.2018.02201","article-title":"Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0278-5846(01)00280-9","article-title":"Effect of low doses of clozapine on behaviour of isolated and group-housed male mice in the elevated plus-maze test","volume":"26","author":"Manzaneque","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0160","unstructured":"Mauri MC, Paletta S, Maffini M, Colasanti A, Dragogna F, Pace C Di, Altamura AC, Health M, Unit P, Neuropsycho- C, Policlinico M, Psychiatry C, Neuropsychopharmacology C, Policlinico OM (2014) Clinical pharmacology of atypical antipsychotics: An update. :1163\u20131191."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2012.05.047","article-title":"Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit\/hyperactivity disorder","volume":"1467","author":"Mc Fie","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0170","doi-asserted-by":"crossref","unstructured":"Mikulska J, Juszczyk G, Gawro M (2021) HPA axis in the pathomechanism of depression and schizophrenia\u202f: new therapeutic strategies based on its participation.","DOI":"10.3390\/brainsci11101298"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0175","doi-asserted-by":"crossref","unstructured":"Mir FA, Jha SK, Nehs CJ (2025) Noradrenergic dysregulation in the locus coeruleus: implications for neuropsychiatric disease pathophysiology- A systematic review. Neurosci Biobehav Rev 179:106442 Available at: https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106442.","DOI":"10.1016\/j.neubiorev.2025.106442"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-020-05679-6","article-title":"Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice","volume":"238","author":"Mosaffa","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pbb.2011.02.009","article-title":"Effects of olanzapine, sertindole and clozapine on learning and memory in the Morris water maze test in naive and MK-801-treated mice","volume":"98","author":"Mutlu","year":"2011","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0195","volume":"1\u201314","author":"Neves","year":"2025","journal-title":"Effects of caffeine on neuroin Fl ammation in anxiety and depression : a systematic review of rodent studies."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0200","doi-asserted-by":"crossref","unstructured":"Norozpour Y, Nasehi M, Sabouri-Khanghah V, Torabi-Nami M, Zarrindast MR (2016) The effect of CA1 \u03b12 adrenergic receptors on memory retention deficit induced by total sleep deprivation and the reversal of circadian rhythm in a rat model. Neurobiol Learn Mem 133:53\u201360 Available at: http:\/\/dx.doi.org\/10.1016\/j.nlm.2016.06.004.","DOI":"10.1016\/j.nlm.2016.06.004"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(00)00105-6","article-title":"Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by \u03b2-adrenoceptors","volume":"23","author":"Ohashi","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0210","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1210\/edrv.22.4.0436","article-title":"Stressor specificity of central neuroendocrine responses: implications for stress-related disorders","volume":"22","author":"Pac\u00e1k","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0215","series-title":"Paxinos and Franklin\u2019s the Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2019"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0220","first-page":"74","article-title":"Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801","volume":"15","author":"Pinar","year":"2015","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"Suppl 8","key":"10.1016\/j.neuroscience.2026.01.035_b0225","first-page":"22","article-title":"Comorbid anxiety and depression","volume":"66","author":"Pollack","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0230","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(00)00129-8","article-title":"The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance","volume":"49","author":"Rasmussen","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0091-3057(97)00461-9","article-title":"Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs","volume":"59","author":"Rex","year":"1998","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0240","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S1734-1140(13)71515-9","article-title":"Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy","volume":"65","author":"Rog\u00f3\u017c","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.173997","article-title":"Divergent effects of noradrenergic activation and orexin receptor 1 blockade on hippocampal structure, anxiety-like behavior, and social interaction following chronic stress","volume":"250","author":"Sarfi","year":"2025","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0250","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety","volume":"21","author":"Schramm","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuroscience.2009.06.022","article-title":"alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis","volume":"163","author":"Shields","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0260","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0028-3908(86)90232-7","article-title":"Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus","volume":"25","author":"Simson","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102162","article-title":"A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex","volume":"88","author":"\u015amia\u0142owska","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0270","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1037\/a0032776","article-title":"Noradrenergic alpha-2 receptor modulators in the ventral bed nucleus of the stria terminalis: effects on anxiety behavior in postpartum and virgin female rats","volume":"127","author":"Smith","year":"2013","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainresbull.2022.10.007","article-title":"Interaction effects of intracerebroventricular injection of crocin with the \u03b1(2)-adrenoceptors on memory deficit and hippocampal synaptic plasticity following chronic pain in rat","volume":"190","author":"Tahmasebi","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0280","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pbb.2017.10.006","article-title":"The antidepressant- and anxiolytic-like effects of fluoxetine and clozapine in chronically isolated rats involve inhibition of hippocampal TNF-\u03b1","volume":"163","author":"Todorovi\u0107","year":"2017","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0290","first-page":"134","article-title":"Use of antipsychotics in the treatment of depressive disorders","volume":"25","author":"Wang","year":"2013","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(00)00628-2","article-title":"Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice","volume":"407","author":"Zarrindast","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.01.035_b0300","first-page":"241","article-title":"Comparison of methods for evaluating drug-drug interaction","volume":"2","author":"Zhao","year":"2010","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.neuroscience.2026.01.035_b0305","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70360","article-title":"Noradrenergic locus coeruleus-CA3 activation alleviates neuropathic pain and anxiety- and depression-like behaviors by suppressing microglial neuroinflammation in SNI mice","volume":"31","author":"Zou","year":"2025","journal-title":"CNS Neurosci. Ther."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:07:34Z","timestamp":1782216454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":61,"alternative-id":["S0306452226000722"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.01.035","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isobolographic analysis of clonidine and clozapine\u2019s antidepressant- and anxiogenic-like effects","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}